Literature DB >> 6163383

Surgical palliation of small bowel obstruction due to metastatic carcinoma.

G V Aranha, F A Folk, H B Greenlee.   

Abstract

Seventy-three patients with small bowel obstruction due to metastatic carcinoma were seen in the years 1960 to 1979. Twenty-nine patients were seen in the first decade and 44 patients in the second. The most common primary tumor causing metastatic small bowel obstruction was colonic carcinoma, followed by gastric carcinoma. Plain x-ray examinations supplemented by an upper gastrointestinal series with small bowel follow-through were the most useful diagnostic tests. Seventy per cent (51/73) of these patients were initially treated with intravenous fluids and gastrointestinal decompression using a short (32/51) or long (19/51) tube. In eight of 51 patients, nasogastric decompression relieved the obstruction, but in all but one of these patients symptoms and signs of obstruction recurred promptly after tube removal. At laparotomy, the majority of patients underwent either a bypass procedure or resection. The mean survival for the patients bypassed varied from four to seven months; for those that had resection it varied from five to nine months. The mortality rate was high--41 per cent in the first decade and 25 per cent in the second. Of the last 12 patients, eight received hyperalimentation before and after surgery. The operative mortality rate was 12.5 per cent and the mean survival was eight months. It is concluded that: 1) Colonic carcinoma is the most common primary tumor causing metastatic small bowel obstruction. 2) Tube decompression is rarely effective and surgical relief is necessary in the vast majority of cases. 3) Operative mortality has been reduced, partially because of more vigorous support, i.e., hyperalimentation, but the mean duration of survival has not changed significantly.

Entities:  

Mesh:

Year:  1981        PMID: 6163383

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

Review 1.  Medical management of intestinal obstruction in terminal care.

Authors:  C Frank
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

Review 2.  Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  Sarah E Cousins; Emma Tempest; David J Feuer
Journal:  Cochrane Database Syst Rev       Date:  2016-01-04

Review 3.  Intraperitoneal immunotherapy: historical perspectives and modern therapy.

Authors:  W F Morano; A Aggarwal; P Love; S D Richard; J Esquivel; W B Bowne
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

4.  Bowel obstruction in patients with metastatic cancer: does intervention influence outcome?

Authors:  Colette R Pameijer; David M Mahvi; James A Stewart; Sharon M Weber
Journal:  Int J Gastrointest Cancer       Date:  2005

5.  Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

Authors:  A C Okaro; D A Fennell; M Corbo; B R Davidson; F E Cotter
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 6.  A case of intestinal hemorrhage due to small intestinal metastases from primary lung cancer.

Authors:  S W Park; H J Cho; W S Choo; K S Chung; H Y Kim; J Y Yoo; J S Kim; H S Shin
Journal:  Korean J Intern Med       Date:  1991-07       Impact factor: 2.884

Review 7.  Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Authors:  Anusha Thadi; Marian Khalili; William F Morano; Scott D Richard; Steven C Katz; Wilbur B Bowne
Journal:  Vaccines (Basel)       Date:  2018-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.